KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) EBT (2016 - 2025)

Evolent Health has reported EBT over the past 12 years, most recently at -$430.8 million for Q4 2025.

  • Quarterly results put EBT at -$430.8 million for Q4 2025, down 1700.81% from a year ago — trailing twelve months through Dec 2025 was -$534.6 million (down 748.14% YoY), and the annual figure for FY2025 was -$534.6 million, down 748.14%.
  • EBT for Q4 2025 was -$430.8 million at Evolent Health, down from -$20.0 million in the prior quarter.
  • Over the last five years, EBT for EVH hit a ceiling of $2.6 million in Q4 2021 and a floor of -$430.8 million in Q4 2025.
  • Median EBT over the past 5 years was -$20.3 million (2025), compared with a mean of -$44.6 million.
  • Biggest five-year swings in EBT: soared 126.33% in 2021 and later crashed 2025.63% in 2023.
  • Evolent Health's EBT stood at $2.6 million in 2021, then plummeted by 493.35% to -$10.2 million in 2022, then plummeted by 370.0% to -$48.1 million in 2023, then skyrocketed by 50.23% to -$23.9 million in 2024, then plummeted by 1700.81% to -$430.8 million in 2025.
  • The last three reported values for EBT were -$430.8 million (Q4 2025), -$20.0 million (Q3 2025), and -$20.7 million (Q2 2025) per Business Quant data.